İsmet KIRPINAR, Erdem DEVECİ, Alperen KILIÇ, Demet ZİHNİ ÇAMUR

Somatizasyon bozukluğu ve hipokondriyazis: Bir elmanın iki yarısımı?

Amaç: DSM-IV, hipokondriyazis ve somatizasyon bozukluğu ayırıcı tanısı için bazı ölçütler sağlamış olsa da, bu bozukluklar arasındaki farklılıklar ender çalışılmıştır. Bu çalışma hipokondriyazis ve somatizasyon bozukluğu arasındaki demografik ve psikometrik özellikleri karşılaştırmayı amaçlamaktadır. Yöntem: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) aracılığı ile ardışık olarak Hipokondriyazis ve Somatizasyon Bozukluğu tanısı alan 18-65 yaşlarındaki 100 hastayı inceledik. Hastalar anksiyete, depresyon, disosiyasyon ve somatosensoryel amplifikasyonu ölçen bir ölçek bataryasını tamamladılar. Results: İki grup arasında istatistiksel olarak anlamlı tek farklılık sağlık anksiyetesi açısındandı. Ortalama Sağlık Anksiyetesi Ölçeği puanı hipokondriyazis grubunda yüksekti. İki grup arasında diğer psikometrik özellikler açısından farklılık yoktu. Conclusion: Sonuçlarımız, hipokondriyazis ve somatoform bozukluğun sağlık anksiyetesi düzeyleri dışında psikolojik değişkenler açısından benzer olduğunu göstermektedir. Hipokondriyazis grubundaki yüksek anksiyete düzeyleri, bu bozukluklarda yeni bir kategorizasyonun gerekli olduğu görüşlerini desteklemektedir.

Somatization disorder and hypochondriasis: as like as two peas?

Objective: Although the DSM-IV has provided some criteria for differential diagnosis of Hypochondriasis and Somatization Disorder, the differences between these disorders have rarely been studied. This study aimed to compare demographic and psychometric properties between hypochondriasis and somatization disorder. Methods: We investigated a sample of 100 patients aged 18-65 years who had been consecutively diagnosed as having hypochondriasis or somatization disorder via the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). The patients completed a battery of scales to measure anxiety, depression, dissociation, and somatosensorial amplification levels. Results: The only statistically significant difference between the two groups was in terms of health anxiety. The mean Health Anxiety Inventory (HAI) score was higher in the hypochondriasis group. No differences arose between the two groups in terms of other psychometric properties. Conclusions: Our results show that except for health anxiety levels, hypochondriasis and somatization disorder are similar in terms of psychological variables. The higher health anxiety levels in the hypochondriasis group support the opinions about the necessity of new categorization in these disorders.

PDF

___

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association, 1994.
2. Leibbrand R, Hiller W, Fichter MM. Hypochond-- riasis and somatization: Two distinct aspects of somatoform disorders? Clin Psychol 2000; 56(1):63-72.
3. Dimsdale J, Creed F. The proposed diagnosis of somatic symptom disorders in DSM-5 to replace somatoform disorders in DSM-lV--a preliminary report. Psychosom Pes 2009; 66(6):473-476.
4. Creed F, Barsky A. systematic review of the epidemiology of somatisation disorder and hypochondriasis. Psychosom Fı'es 2004; 56(4).'391- 408.
5. Creed F. Should general psychiatry ignore somatization and hypochondriasis? World Psychiatry 2006; 5(3):146.
6. Fink P, anbal E, Toft T, Spar/e KC, Frostholm L, Olesen F. new, empirically established hypochondriasis diagnosis. Am Psychiatry 2004; 161(9):1680-1691.
7. Barsky AJ, Wyshak G, Klerman GL. Psychiatric comorbidity in DSM--IlI-R hypochondriasis. Arch Gen Psychiatry 1992; 49(2):101- 108.
8. Dimsdale J, Sharma N, Sharpe M. What do physicians think of somatoform disorders? Psycho-- somatics 201 52(2):154- 159.
9. Escobar JI, Swartz M, Rubio-Stipec M, Manu P. Medically unexplained symptoms: distribution, risk factors, and comorbidity. LJ Kirmeyer, JM Robbins (Eds), Current Concepts of Somatization: Research and Clinical Perspectives. Washington, DC: American Psychiatric Press, 1991, p.63-78.
10. Schmidt A. Bottlenecks in the diagnosis of hypochondriasis. Compr Psychiatry 1994; 35(4).'306-- 315.
11. Kroenke K, Sharpe M, Sykes R. Revising the classification of somatoform disorders: key questions and preliminary recommendations. Psychosomatics 2007; 48(4):277--285.
12. Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders critical review of previous intervention studies. Psychosom Med 2007; 69(9).'889--900.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association, 2013.
14. Noyes R, Stuart S, Watson DB, Langbehn DR. Distinguishing between hypochondriasis and somatization disorder: review of the existing literature. Psychother Psychosom 2006; 75(5):270-281.
Rief W, Hil/er W, Margraf J. Cognitive aspects of hypochondriasis and the somatization syndrome. Abnorm Psychol 1998; 107(4):587.
Olatunji BO, Deacon BJ, Abramowitz JS. Is hypochondriasis an anxiety disorder? Br Psychiatry 2009; 194(6):481 -482.
Çorapçıoğlu A, Aydemir Ö, Yıldız M, Esen A, Köroğlu E. DSM--IV Eksen Bozuklukları (SCID-I) için Yapılandırılmış Klinik Görüşme, Klinik Versiyon. Ankara: Hekimler Yayın Birliği, 1999.
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. Consult Clin Psychol 1988; 56(6):893.
Ulusoy M, Sahin N, Erkmen H. Turkish version of the Beck Anxiety Inventory: psychometric properties. Journal of Cognitive Psychotherapy 1998; 12:163-172.
Williams JB. structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988; 45(8):742--747.
Akdemir A, Örsel 8, Dağ i, Türkçapar H, İşcan N, Özbay H. Hamilton depresyon derecelendirme ölçeğinin (HDDÖ) geçerliği, güvenirliği ve klinikte kullanımı. 3P Dergisi 1996; 4(4):251-259.
Barsky AJ, Wyshak G, Klerman GL. The somatosensory amplification scale and its relationship to hypochondriasis. Psychiatr Res 1990; 24(4):323-234.
Güleç H, Sayar K, Güleç M. Bedensel Duyumları Abartma Ölçeği Türkçe Formunun geçerlik ve güvenirliği. Düşünen Adam: Psikiyatri ve Nörolojik Bilimler Dergisi 2007; 20( 1): 6-24.
Nijenhuis ER, Spinhoven P, Van Dyck R, Van Der Hart 0, Vanderlinden J. The development and psychometric characteristics of the Somatoform Dissociation Questionnaire (SDQ-20). The Journal of Nervous and Mental Disease 1996; 184(1 1):688--694.
Sar V, Kundakci T, Kizi/tan E, Bahadir B, Aydiner 0. Reliability and validity of the Turkish version of the Somatoform Dissociation Questionnaire (SDQ-20). Proceeding of the International Society of Dissociation 15"7 International Fall Conference Seattle, 1998.
Carlson EB, Putnam FW, Ross CA, Torem M, Coons P, DiII DL, et a/. Validity of the Dissociative
Anatolian Journal of Psychiatry 2016; 17(3):165-173 Experiences Scale in screening for multiple personality disorder: mu/ticenter study. Am Psychiatry 1993; 150(7): 030- 036.
Yargic LI, Tutkun H, Sar V. Reliability and validity of the Turkish version of the Dissociative Experiences Scale. Dissociation: Progress in the Dissociative Disorders 1995; 8:10-13.
Salkovskis PM, Bimes KA, Warwick H, Clark D. The Hea/th Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med 2002; 32(05):843-853.
Aydemir Ö, Kirpinarl, Sati T, Uykur B, Cengisiz C: Reliability and validity of the Turkish version of the health anxiety inventory. Noropsikiyatri Arsivi 2013; 50(4):325-331.
Spielberger CD, Gorsuch RL, Lushene RE. Manual for the state-trait anxiety inventory. California, Consulting Psychologists Press, 1970.
Öner N, LeCompte_ WA. Durumluk--Sürekli Kaygı Envanteri El Kitabı. Istanbul: Boğaziçi Üniversitesi, 1983.
Kuwabara H, Otsuka M, Shindo M, Ono S, Shioiri T, Someya T. Diagnostic classification and demographic features in 283 patients with somatoform disorder. Psychiatry Clin Neurosci 2007; 61 (3):283--289.
Lipowski Z. Somatization: border/and between medicine and psychiatry. CMAJ 1986; 135(6):609. Rief W, Barsky AJ. Psychobiological perspectives on somatoform disorders. Psychoneuroendoc-- rinology 2005; 30(10):996- 1002.
Bridges K, Goldberg D, Evans B, Sharpe T. Deter-- minants of somatization in primary care. Psychol Med 1991; 21 (02):473--83.
Nemiah JC: reconsideration of psychological specificity in psychosomatic disorders. Psychother Psychosom 1982,'38(1 -4):39--45.
Noyes R, Stuart SP, Watson DB. reconceptualization of the somatoform disorders. Psychosomatics 2008; 49(1): 14-22.
Rief W, Broadbent E. Explaining medically unexplained symptoms--models and mechanisms. Clin Psychol Rev 2007; 27(7):821-841.
Katon W, Sullivan M, Walker E. Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med 2001; 134(9):917--925.
Lieb R, Pfister H, Mastaler M, Wittchen HU. Somatoform syndromes and disorders in repre-- sentative population sample of adolescents and young adults: prevalence, comorbidity and impairments. Acta Psychiatr Scand 2000; 101(3):194-- 208.
Löwe B, Spitzer RL, Williams JB, Mussell M, Schellberg D, Kroenke K. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry 2008; 30(3).'191-199.
Noyes Jr R. The relationship of hypochondriasis to anxiety disorders. Gen Hosp Psychiatry 1999; 21(1):8-17.
Lieb R, Meinlschmidt G, Araya R. Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: an update. Psychosom Med 2007; 69(9).'860-863.
Abramowitz JS, Schwartz SA, Whiteside SP. contemporary conceptual model of hypochondriasis. Mayo Clin Proc 2002; 77:1323-1330.
Salkovskis PM, Warwick HMC. Meaning, misinterpretations, and medicine: cognitive-behavioral approach to understanding health anxiety and hypochondriasis. Starcevic, DR Lipsitt (Eds), Hypochondriasis: Modern Perspectives on an Ancient Malady. New York: Oxford University Press, 2001, p.202-222.
Hil/er W, Fichter MM, Rief W. controlled treatment study of somatoform disorders including ana-- lysis of healthcare utilization and cost--effective-- ness. Psychosom Res 2003; 54(4):369-380.
Sifneos PE. The prevalence of 'alexithymic' characteristics in psychosomatic patients. Psychother Psychosom 1973; 22(2-6):255-262.
De Gucht V, Heiser W. Alexithymia and somatisation: quantitative review of the literature. Psychosom Res 2003; 54(5):425--434.
Matti/a AK, Kronholm E, Jula A, Salminen JK, Koivisto AM, Mielonen RL, et al. Alexithymia and somatization in general population. Psychosom Med 2008; 70(6) :716- 722.
Pribor EF, Yutzy SH, Dean JT, Wetzel RD. Briquet's syndrome, dissociation, and abuse. Am Psychiatry 1993; 150(10):1507--1511.
Saxe GN, Chinman G, Berkowitz R, Hall K, Lieberg G, Schwartz J, et al. Somatization in patients with dissociative disorders. Am Psychiatry 1994;151(9):1329--1334.
Othmer E, DeSouza C. screening test for somatization disorder (hysteria). Am Psychiatry 1985; 142:1146-1149.
Nijenhuis ER. Somatoform dissociation: major symptoms of dissociative disorders. Journal of Trauma Dissociation 2001; 1(4):7--32.
Bailer J, Kerstner T, Witthöft M, Diener C, Mier D, Rist F. Health anxiety and hypochondriasis in the light of DSM--5. Anxiety, Stress, Coping: An International Journal, DOI: 10. 1080/10615806.2015. 1036243.
Olatunji BO, Kauffman BY, Meltzer S, Davis ML, Smits JAJ, Powers MB. Cognitive-behavioral therapy for hypochondriasis/health anxiety: metaana/ysis of treatment outcome and moderators. Behav Res Ther 2014; 58: 65--74.
Rief W, Martin A. How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: critical evaluation and proposal for modifications. Ann Rev Clin Psychol 2014; 10:339-367.
Rodriguez-Testa! JF, Senin-Calderon C, PeronaGarcelan S. From DSM-lV-TR to DSM-5: Analysis of some changes. lntJ Clinical and Health Psychology 2014; 14: 221-231.
van den Heuvel OA, Veale D, Stein DJ. Hypochondriasis: considerations for ICD-11. Revista Brasileira de Psiquiatria 2014; 36:S21-S27.
Starcevic V. Hypochondriasis and health anxiety: conceptual challenges. Br Psychiatry 2013; 202:7-8.